BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 26996790)

  • 1. [Pediatric medulloblastoma: Retrospective series of 52 patients].
    Vigneron C; Antoni D; Coca A; Entz-Werlé N; Lutz P; Spiegel A; Jannier S; Niederst C; Jarnet D; Meyer P; Kehrli P; Noël G
    Cancer Radiother; 2016 Apr; 20(2):104-8. PubMed ID: 26996790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adult medulloblastoma: Retrospective series of 21 patients].
    Vigneron C; Antoni D; Coca A; Niederst C; Jarnet D; Meyer P; Kehrli P; Noël G
    Cancer Radiother; 2016 Feb; 20(1):14-7. PubMed ID: 26706607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: a prospective observational multicentre study.
    Friedrich C; von Bueren AO; von Hoff K; Kwiecien R; Pietsch T; Warmuth-Metz M; Hau P; Deinlein F; Kuehl J; Kortmann RD; Rutkowski S
    Eur J Cancer; 2013 Mar; 49(4):893-903. PubMed ID: 23182688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy after reduced craniospinal irradiation dose in children with average-risk medulloblastoma: a 5-year follow-up study.
    Wahba HA; Abu-Hegazy M; Wasel Y; Ismail EI; Zidan AS
    J BUON; 2013; 18(2):425-9. PubMed ID: 23818356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.
    Packer RJ; Sutton LN; Elterman R; Lange B; Goldwein J; Nicholson HS; Mulne L; Boyett J; D'Angio G; Wechsler-Jentzsch K
    J Neurosurg; 1994 Nov; 81(5):690-8. PubMed ID: 7931615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy and adjuvant chemotherapy for childhood medulloblastoma. The Royal Marsden Hospital experience.
    Whitton AC; Syndikus I; Tait DM; Bloom HJ
    Strahlenther Onkol; 1995 Nov; 171(11):615-21. PubMed ID: 7502224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local control in non-metastatic medulloblastoma.
    Christopherson KM; Bradley JA; Rotondo RL; Pincus DW; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
    Acta Oncol; 2014 Sep; 53(9):1151-7. PubMed ID: 24991891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experience.
    Atalar B; Ozsahin M; Call J; Napieralska A; Kamer S; Villa S; Erpolat P; Negretti L; Lassen-Ramshad Y; Onal C; Akyurek S; Ugurluer G; Baumert BG; Servagi-Vernat S; Miller RC; Ozyar E; Sio TT
    Radiother Oncol; 2018 Apr; 127(1):96-102. PubMed ID: 29373196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and outcomes of medulloblastoma in adults.
    Ang C; Hauerstock D; Guiot MC; Kasymjanova G; Roberge D; Kavan P; Muanza T
    Pediatr Blood Cancer; 2008 Nov; 51(5):603-7. PubMed ID: 18649371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitrogen mustard, vincristine, procarbazine, and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma. A Pediatric Oncology Group study.
    Krischer JP; Ragab AH; Kun L; Kim TH; Laurent JP; Boyett JM; Cornell CJ; Link M; Luthy AR; Camitta B
    J Neurosurg; 1991 Jun; 74(6):905-9. PubMed ID: 2033450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.
    Gajjar A; Chintagumpala M; Ashley D; Kellie S; Kun LE; Merchant TE; Woo S; Wheeler G; Ahern V; Krasin MJ; Fouladi M; Broniscer A; Krance R; Hale GA; Stewart CF; Dauser R; Sanford RA; Fuller C; Lau C; Boyett JM; Wallace D; Gilbertson RJ
    Lancet Oncol; 2006 Oct; 7(10):813-20. PubMed ID: 17012043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter experience of adult medulloblastoma: A study of Anatolian Society of Medical Oncology (ASMO).
    Esbah O; Demirci U; Dane F; Gunaydsin Y; Ozdemir N; Siyar Ekinci A; Kodaz H; Yazilitas D; Rzayev R; Guney Y; Seker M; Uysal M; Inal A; Bilici A; Benekli M; Oksuzoglu B; Buyukberber S
    J BUON; 2016; 21(2):456-60. PubMed ID: 27273958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multivariate analysis of prognostic factors in adult patients with medulloblastoma. Retrospective study of 156 patients.
    Carrie C; Lasset C; Alapetite C; Haie-Meder C; Hoffstetter S; Demaille MC; Kerr C; Wagner JP; Lagrange JL; Maire JP
    Cancer; 1994 Oct; 74(8):2352-60. PubMed ID: 7922986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology.
    von Bueren AO; von Hoff K; Pietsch T; Gerber NU; Warmuth-Metz M; Deinlein F; Zwiener I; Faldum A; Fleischhack G; Benesch M; Krauss J; Kuehl J; Kortmann RD; Rutkowski S
    Neuro Oncol; 2011 Jun; 13(6):669-79. PubMed ID: 21636711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Brain tumors in infants and children--factors affecting prognosis, (Part-3). Mode of metastasis and prognosis in medulloblastoma].
    Oi S; Matsumoto S; Raimondi AJ
    No Shinkei Geka; 1985 Dec; 13(12):1273-80. PubMed ID: 4088449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preirradiation chemotherapy including "eight drugs in 1 day" regimen and high-dose methotrexate in childhood medulloblastoma: results of the M7 French Cooperative Study.
    Gentet JC; Bouffet E; Doz F; Tron P; Roche H; Thyss A; Plantaz D; Stephan JL; Mottolese C; Ponvert D
    J Neurosurg; 1995 Apr; 82(4):608-14. PubMed ID: 7897523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medulloblastomas--the results after postoperative radiotherapy with and without adjuvant chemotherapy].
    Grabenbauer GG; Löhnert C; Erhardt J; Buchfelder M; Neubauer U; Beck JD; Reitz S; Seyer H; Thierauf P; Fietkau R
    Strahlenther Onkol; 1993 Apr; 169(4):213-21. PubMed ID: 8488458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of pediatric average-risk medulloblastoma using craniospinal irradiation less than 2500 cGy and chemotherapy: single center experience in Korea.
    Yoon JH; Park KD; Kang HJ; Kim H; Lee JW; Kim SK; Wang KC; Park SH; Kim IH; Shin HY
    World J Pediatr; 2017 Aug; 13(4):367-373. PubMed ID: 28550392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival of adults treated for medulloblastoma using paediatric protocols.
    Spreafico F; Massimino M; Gandola L; Cefalo G; Mazza E; Landonio G; Pignoli E; Poggi G; Terenziani M; Pedrazzoli P; Siena S; Fossati-Bellani F
    Eur J Cancer; 2005 Jun; 41(9):1304-10. PubMed ID: 15869875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of adults with medulloblastoma: a prospective study.
    Brandes AA; Ermani M; Amista P; Basso U; Vastola F; Gardiman M; Iuzzolino P; Turazzi S; Rotilio A; Volpin L; Mazza C; Sainati L; Ammannati F; Berti F
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):755-61. PubMed ID: 14529781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.